GKHT Medical Technology Co., Ltd. (SHE:301370)
China · Delayed Price · Currency is CNY 8.95
-0.17 (-1.86%)
Jun 10, 2026, 4:00 PM EDT
GKHT Medical Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 6,769 | 6,940 | 7,303 | 7,446 | 6,327 | 5,814 |
Other Revenue | 47.08 | 47.08 | 43.34 | 36.81 | 32.6 | 32.9 |
| 6,816 | 6,987 | 7,346 | 7,483 | 6,360 | 5,847 | |
Revenue Growth (YoY) | -7.51% | -4.89% | -1.82% | 17.66% | 8.76% | 20.27% |
Cost of Revenue | 6,170 | 6,324 | 6,579 | 6,626 | 5,536 | 5,043 |
Gross Profit | 646.78 | 663.09 | 767.52 | 856.87 | 823.84 | 804.55 |
Selling, General & Admin | 490.99 | 509.28 | 514.73 | 513.18 | 442.53 | 386.44 |
Research & Development | 12.01 | 10.35 | 10.95 | 12.9 | 12.4 | 10.55 |
Other Operating Expenses | 21.3 | 22.12 | 21 | 19.25 | 19.47 | 19.2 |
Operating Expenses | 512.28 | 537.17 | 537.8 | 530.41 | 501.53 | 440.1 |
Operating Income | 134.5 | 125.92 | 229.72 | 326.46 | 322.32 | 364.45 |
Interest Expense | -30.9 | -34.35 | -60.95 | -88.18 | -119.32 | -128.96 |
Interest & Investment Income | 3.47 | 4.33 | 6.34 | 5.62 | 3.18 | 2.85 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.07 | -0.1 | -0.28 | 0.18 |
Other Non Operating Income (Expenses) | -19.62 | -20.47 | -5.59 | -8.37 | -19.32 | -8.46 |
EBT Excluding Unusual Items | 87.42 | 75.42 | 169.45 | 235.43 | 186.58 | 230.07 |
Gain (Loss) on Sale of Investments | -3.34 | -2.49 | -0.52 | -4.99 | - | - |
Gain (Loss) on Sale of Assets | -0.09 | 0.12 | -0.21 | -0.18 | 0.22 | -0.03 |
Asset Writedown | -1.37 | -0.59 | -0.07 | -0.81 | -0.22 | 0.01 |
Other Unusual Items | 19.99 | 19.74 | 20.22 | 6.63 | 9.23 | 11.78 |
Pretax Income | 102.61 | 92.21 | 188.86 | 236.08 | 195.81 | 241.84 |
Income Tax Expense | 30.05 | 27.61 | 37.13 | 65.37 | 53.71 | 62 |
Earnings From Continuing Operations | 72.56 | 64.6 | 151.74 | 170.71 | 142.1 | 179.84 |
Minority Interest in Earnings | 5.79 | 3.55 | -21.07 | -16.83 | -17.19 | -28.63 |
Net Income | 78.35 | 68.15 | 130.66 | 153.88 | 124.91 | 151.21 |
Net Income to Common | 78.35 | 68.15 | 130.66 | 153.88 | 124.91 | 151.21 |
Net Income Growth | -16.75% | -47.84% | -15.09% | 23.19% | -17.39% | 3.55% |
Shares Outstanding (Basic) | 479 | 487 | 467 | 427 | 403 | 398 |
Shares Outstanding (Diluted) | 479 | 487 | 467 | 427 | 403 | 398 |
Shares Change (YoY) | 3.24% | 4.31% | 9.17% | 6.08% | 1.26% | 0.83% |
EPS (Basic) | 0.16 | 0.14 | 0.28 | 0.36 | 0.31 | 0.38 |
EPS (Diluted) | 0.16 | 0.14 | 0.28 | 0.36 | 0.31 | 0.38 |
EPS Growth | -19.36% | -50.00% | -22.22% | 16.13% | -18.42% | 2.70% |
Free Cash Flow | 235.88 | 646.05 | 606.32 | 562.37 | 214.1 | 145.78 |
Free Cash Flow Per Share | 0.49 | 1.33 | 1.30 | 1.32 | 0.53 | 0.37 |
Dividend Per Share | 0.122 | 0.122 | 0.084 | 0.118 | - | - |
Dividend Growth | 45.24% | 45.24% | -28.81% | - | - | - |
Gross Margin | 9.49% | 9.49% | 10.45% | 11.45% | 12.95% | 13.76% |
Operating Margin | 1.97% | 1.80% | 3.13% | 4.36% | 5.07% | 6.23% |
Profit Margin | 1.15% | 0.97% | 1.78% | 2.06% | 1.96% | 2.59% |
Free Cash Flow Margin | 3.46% | 9.25% | 8.25% | 7.51% | 3.37% | 2.49% |
EBITDA | 162.49 | 159.76 | 286.95 | 368.63 | 363.89 | 391.73 |
EBITDA Margin | 2.38% | 2.29% | 3.91% | 4.93% | 5.72% | 6.70% |
D&A For EBITDA | 27.99 | 33.84 | 57.23 | 42.17 | 41.57 | 27.28 |
EBIT | 134.5 | 125.92 | 229.72 | 326.46 | 322.32 | 364.45 |
EBIT Margin | 1.97% | 1.80% | 3.13% | 4.36% | 5.07% | 6.23% |
Effective Tax Rate | 29.29% | 29.95% | 19.66% | 27.69% | 27.43% | 25.64% |
Revenue as Reported | 6,816 | 6,987 | 7,346 | 7,483 | 6,360 | - |